Basaloid squamous cell carcinoma in the nasal cavity treated with proton beam therapy concurrent with cisplatin: A case report

被引：4

作者：

Takamatsu S. ^{[1
]}

Yamamoto K. ^{[1
]}

Kondou T. ^{[2
]}

Kawamura M. ^{[1
]}

Asahi S. ^{[1
]}

Tameshige Y. ^{[1
]}

Maeda Y. ^{[1
]}

Sasaki M. ^{[1
]}

Tamamura H. ^{[1
]}

Tsuji A. ^{[3
]}

Kaizaki Y. ^{[4
]}

Kumano T. ^{[5
]}

Takanaka T. ^{[5
]}

机构：

[1] Proton Therapy Center, Fukui Prefectural Hospital, Fukui City, Fukui 910-8526

[2] Department of Diagnostic and Therapeutic Radiology, Kanazawa Medical University, Uchinada, Kahoku, Ishikawa 920-0923

[3] Division of Otolaryngology Head and Neck Surgery, Graduate School of Medicine, Kanazawa University, Kanazawa city, Ishikawa 920-8640

[4] Department of Pathology, Fukui Prefectural Hospital, Fukui City, Fukui 910-8526

[5] Department of Radiotherapy, Graduate School of Medicine, Kanazawa University, Kanazawa city, Ishikawa 920-8640

来源：

Journal of Medical Case Reports | / 8卷 / 1期

关键词：

Basaloid squamous cell carcinoma; Cisplatin; Concurrent radiochemotherapy; Nasal cavity; Proton beam therapy;

D O I：

10.1186/1752-1947-8-123

中图分类号：

学科分类号：

摘要：

Introduction. Basaloid squamous cell carcinoma is a rare and aggressive variant of squamous cell carcinoma. Basaloid squamous cell carcinoma is mostly seen in the upper aerodigestive tract and has a propensity for lymph node spread and systemic metastases. Various treatment modalities have been reported, including surgical excision supplemented with radiotherapy/adjuvant chemotherapy. To the best of our knowledge, treatment of nasal basaloid squamous cell carcinoma with proton beam therapy and cisplatin has not been described in the literature. Case presentation. We report the case of a 56-year-old Japanese man with locally invasive basaloid squamous cell carcinoma in his right nasal cavity with invasion of the orbit, paranasal sinus, and buccal subcutaneous tissue. He underwent proton beam therapy concurrent with cisplatin. Acute and late side effects did not exceed grade 3. At 24-month follow up, he remains in complete remission. Conclusion: Proton beam therapy concurrent with cisplatin may be one choice for locally invasive basaloid squamous cell carcinoma. © 2014 Takamatsu et al.; licensee BioMed Central Ltd.

引用

共 13 条

[1]

Wain S.L., Kier R., Vollmer R.T., Bossen E.H., Basaloid-squamous carcinoma of the tongue, hypopharynx, and larynx: Report of 10 cases, Human Pathology, 17, 11, pp. 1158-1166, (1986)

[2]

Oikawa K., Tabuchi K., Nomura M., Okubo H., Wada T., Iijima T., Hara A., Basaloid squamous cell carcinoma of the maxillary sinus: A report of two cases, Auris Nasus Larynx, 34, 1, pp. 119-123, (2007)

[3]

Gu X., Eskandari F., Fowler M., Sphenoid sinus basaloid squamous cell carcinoma presenting as a sellar mass: Report a case with review of the literature, Head Neck Pathol, 5, pp. 81-85, (2011)

[4]

Ferlito A., Rinaldo A., Altavilla G., Doglioni C., Basaloid squamous cell carcinoma of the larynx and hypopharynx, Annals of Otology, Rhinology and Laryngology, 106, 12, pp. 1024-1035, (1997)

[5]

Lee J.S., Ko J.I., Jun S.Y., Kim J.Y., Basaloid squamous cell carcinoma in nasal cavity, Clin Exp Otorhinolaryngol, 2, pp. 207-210, (2009)

[6]

Vasudev P., Boutross-Tadross O., Radhi J., Basaloid squamous cell carcinoma: Two case reports, Cases J, 2, (2009)

[7]

Hoy N., Wong J., Mahmood M., Brassard A., Basaloid squamous cell carcinoma of the nasal septum presenting as a primary cutaneous lesion, J Cutan Med Surg, 16, pp. 375-377, (2012)

[8]

Al-Sarraf M., LeBlanc M., Giri P.G.S., Fu K.K., Cooper J., Vuong T., Forastiere A.A., Adams G., Sakr W.A., Schuller D.E., Ensley J.F., Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099, Journal of Clinical Oncology, 16, 4, pp. 1310-1317, (1998)

[9]

Pignon J.P., Bourhis J., Domenge C., Designe L., Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data, Lancet, 355, 9208, pp. 949-955, (2000)

[10]

Adelstein D.J., Li Y., Adams G.L., Wagner Jr.H., Kish J.A., Ensley J.F., Schuller D.E., Forastiere A.A., An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer, J Clin Oncol, 21, pp. 92-98, (2003)

← 1 2 →